| Course | NSG 318 Introduction to Pharmacology |
|---|---|
| Topic | Topic 2 |
| Paper type | Receptor pharmacology paper |
| Length | About 960 words, 3 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | BSN |
| Updated | October 2026 |
Free sample paper for NSG 318 Topic 2
One Fact, Many Effects: Deriving Beta Blocker Nursing Care From Receptor Antagonism in a 66-Year-Old Man With Angina and Asthma
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
NSG-318: Introduction to Pharmacology
Topic 2 Assignment
[Instructor Name]
September 14, 2026
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
One Fact, Many Effects: Deriving Beta Blocker Nursing Care From Receptor Antagonism in a 66-Year-Old Man With Angina and Asthma
Receptors in General
A receptor is a protein, usually on a cell surface, that a drug or a natural chemical binds to in order to change what the cell does. A drug that binds and activates the receptor, producing the same effect as the body's own chemical, is an agonist. A drug that binds and blocks the receptor, preventing the body's chemical from acting, is an antagonist. An antagonist does nothing by itself; its effect is to reduce whatever the body's chemical would have done (Burchum & Rosenthal, 2022). This single distinction explains most of what a nurse needs to know about beta blockers.
The sympathetic nervous system releases norepinephrine and epinephrine, which act on several receptor types, including beta-1 and beta-2 receptors. Beta-1 receptors are found mainly in the heart, where stimulation increases heart rate, the force of contraction and the speed of conduction through the atrioventricular node, and in the kidney, where stimulation releases renin. Beta-2 receptors are found in the smooth muscle of the airways, where stimulation relaxes the muscle and widens the bronchi, as well as in blood vessels and the liver.
Deriving the Expected Effects
Beta blockers are antagonists at beta receptors. From that one fact, the expected cardiac effects follow. Blocking beta-1 receptors in the heart slows the heart rate, reduces the force of contraction and slows conduction through the atrioventricular node. Blocking beta-1 receptors in the kidney reduces renin release, which lowers angiotensin II and aldosterone. The combined result is lower blood pressure and a heart that uses less oxygen, which is why beta blockers relieve angina: a slower, less forceful heart needs less blood flow from narrowed coronary arteries.
Mr. A. K., a composite 66-year-old man with stable angina, has chest pain when he climbs the stairs to his apartment. His resting heart rate is 88. A beta blocker is expected to lower his heart rate, reduce the work of his heart on exertion and raise the level of activity he can reach before pain begins. The nurse can predict what to measure before each dose from the mechanism alone: heart rate and blood pressure, because both are the intended effects and both can go too far.
Selectivity
Beta blockers differ in which receptors they block. Nonselective beta blockers, such as propranolol, block both beta-1 and beta-2 receptors. Cardioselective beta blockers, such as metoprolol and bisoprolol, block beta-1 receptors more than beta-2 at usual doses. The difference matters because Mr. K. also has mild persistent asthma, controlled with an inhaled corticosteroid and an albuterol inhaler as needed. Albuterol is a beta-2 agonist; it opens his airways by stimulating the very receptors a nonselective beta blocker would block. A nonselective beta blocker in a person with asthma blocks the receptor his rescue inhaler depends on, which can cause bronchospasm and make the inhaler less effective when he needs it most.
Evidence supports the distinction. A systematic review and meta-analysis of randomized trials of single doses of beta blockers in people with asthma found that both types could reduce lung function, but that nonselective agents caused larger falls and a greater reduction in the response to beta-agonist treatment than cardioselective agents (Morales et al., 2014). Selectivity is relative, not absolute: at higher doses, a cardioselective drug also blocks some beta-2 receptors. A review of cardioselective beta blockers in chronic obstructive pulmonary disease reached a similar reassuring conclusion for that population (Salpeter et al., 2005). For Mr. K., the prescriber chooses a cardioselective beta blocker at a low starting dose.
Adverse Effects From the Same Mechanism
The adverse effects are the expected effects in excess or in the wrong place. Bradycardia and hypotension are the intended effects gone too far. Fatigue and reduced exercise tolerance follow from a heart that cannot speed up as much with effort. Heart block can occur because conduction through the atrioventricular node is slowed. In a person with diabetes, beta blockade can hide the rapid heartbeat and tremor that warn of hypoglycemia, since those warning signs are produced by sympathetic stimulation. And stopping a beta blocker abruptly after long-term use can cause rebound tachycardia and worsen angina, because the heart has adapted to the blockade with more receptors. Each of these can be predicted rather than memorized.
Nursing Care Derived From the Mechanism
The nursing care for Mr. K. follows directly. Before each dose, the nurse checks his apical heart rate and blood pressure and holds the dose and notifies the provider if the heart rate or blood pressure is below the parameters ordered, commonly a heart rate under 60 or a systolic pressure under 100, unless otherwise specified. She listens to his lungs and asks about wheeze or chest tightness, especially in the first days and after dose increases, and makes sure his albuterol inhaler is with him. She teaches him not to stop the medication suddenly, to rise slowly from sitting, and to report dizziness, fainting, worsening shortness of breath or a pulse below 50 if he checks it at home. She tells him that he may feel more tired for the first few weeks, which usually improves. Every item on that list comes from knowing that the drug blocks beta receptors, mostly beta-1, and that his airways depend on beta-2.
Knowing the mechanism also tells the nurse what not to worry about. A drop in heart rate from 88 to 68 after the first week is not a problem to report; it is the drug working, and it is what allows Mr. K. to climb the stairs without pain. What would be worth reporting is a rate below 55, dizziness when he stands, or new wheeze.
References
Burchum, J. R., & Rosenthal, L. D. (2022). Lehne's pharmacology for nursing care (11th ed.). Elsevier.
Morales, D. R., Jackson, C., Lipworth, B. J., Donnan, P. T., & Guthrie, B. (2014). Adverse respiratory effect of acute beta-blocker exposure in asthma: A systematic review and meta-analysis of randomized controlled trials. Chest, 145(4), 779-786. https://doi.org/10.1378/chest.13-1235
Salpeter, S. R., Ormiston, T. M., & Salpeter, E. E. (2005). Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, (4), Article CD003566. https://doi.org/10.1002/14651858.CD003566.pub2
Reading the GCU NSG 318 Topic 2 instructions
Topic 2 in NSG-318 asks students to explain how a drug's mechanism of action produces its effects and nursing implications. Strong papers start from the receptor, explaining agonists and antagonists, then derive the expected effects of the drug class from that single fact rather than memorizing lists. Students should explain selectivity and why it matters for a patient with a coexisting condition, show that adverse effects follow from the same mechanism in excess or in other tissues and derive nursing care, such as heart rate checks and hold parameters, from the mechanism. A care plan format is usually not required; the reasoning from mechanism to action is what is graded.
How this NSG 318 Topic 2 example is built
What the example shows is a mechanism argued forward into nursing care. It opens with receptors in general terms, a drug binding a site and either activating or blocking it, then narrows to beta-1 receptors in the heart and beta-2 receptors in the airways. The beta blocker class is introduced as antagonists, and the paper derives its expected effects from that single fact: a slower heart rate, lower blood pressure and reduced force of contraction. Selectivity follows, explaining why a nonselective agent can tighten the airways of a patient with asthma while a cardioselective one is less likely to at usual doses. A composite patient appears for the application, and the paper states which vital signs are taken before administration, where a hold parameter from the order enters, and which symptoms are reported afterward. Sources are cited throughout.
NSG 318 Topic 2 rubric: what Excellent looks like
Faculty reward care derived from the mechanism. An Excellent paper explains receptor antagonism, then derives slower heart rate and reduced contractility from beta-1 blockade. Credit goes to explaining why a nonselective agent such as propranolol is risky with asthma, citing Morales and colleagues, while Salpeter and colleagues support cardioselective agents. The rubric values adverse effects explained as expected effects in excess, such as bradycardia. Strong papers use Burchum and Rosenthal. Top marks go to hold parameters and wheeze checks derived from the mechanism.
NSG 318 Topic 2 help before you submit
Deductions here tend to begin with a mechanism described and then abandoned. A paragraph explaining that beta blockers are antagonists at beta receptors is accurate, yet if nothing afterward uses that fact to predict a nursing check, the application criterion gets little. Papers also lose points by listing adverse effects without tracing them to the receptor, which reads as memorization and offers no help with a different drug. Missing the selectivity distinction is a content error that surfaces as unsafe reasoning about a patient with lung disease. Some writers name the pulse check but never say what result would lead to withholding it and notifying the prescriber, and that decision is the nurse's contribution. Strong versions finish by predicting the checks for a drug the paper never discussed, using only the receptor it acts on.
Get an NSG-318 Topic 2 example written to your instructions
Send the NSG-318 Topic 2 instructions, rubric and any drug class the prompt assigns. We write a custom example to them, deriving effects and nursing checks from the mechanism and using a composite patient, and return it in 24 to 48 hours. The first one is free. Any parameter or value in it is illustrative, never guidance for real care.
More NSG 318 papers and BSN samples
- NSG 318 Topic 1: Pharmacokinetics Application Paper
- NSG 318 Topic 3: Drug Class Profile
- NSG 318 Topic 4: Adverse Effect Analysis
- NSG 318 Topic 5: Drug Interaction DQ
- NSG 318 Topic 6: Special Population Dosing Paper
- NSG 318 Topic 7: Medication Administration Case Study
- NSG 318 Topic 8: Medication Teaching Plan
- NSG 320 Topic 2: Fluid Electrolyte Case Analysis
- NSG 310 Topic 2: Licensure History Paper
- NSG 322 Topic 2: Process Recording
- NSG 300 Topic 2: Nursing Process Application
NSG 318 Topic 2 questions, answered
Why start from the receptor instead of the drug?
Because the receptor explains the class. Once it is clear that a drug blocks beta-1 sites, the slower pulse, the lower pressure and the fatigue follow without memorizing each one separately. Nursing programs often teach it this way because new agents keep arriving, and a nurse who reasons from the mechanism can anticipate the checks from the mechanism alone.
What is a hold parameter?
A threshold written into the order or a facility policy, such as a heart rate or blood pressure below which the dose is not given and the prescriber is notified. The example shows that a parameter exists and where it enters the reasoning, but the specific number always comes from the order and policy in front of the nurse, never from a sample paper.
Does this topic need a care plan format?
Usually not. The deliverable is typically a short paper or structured analysis focused on mechanism and monitoring, and a full care plan with diagnoses and goals belongs to other courses. Read your instructions for the required format. If a table is allowed, a layout of receptor, effect and nursing check often makes the reasoning easy for a grader to follow.
Where can I find a free NSG 318 Topic 2 sample paper?
The receptor paper for NSG 318 Topic 2 covers receptors in general, deriving the expected effects, selectivity, adverse effects from the same mechanism and nursing care derived from the mechanism. Share your NSG 318 Topic 2 prompt for a free paper.
What is a hold parameter in NSG 318 Topic 2?
A threshold written into the order, such as holding the dose if heart rate is below 55 or systolic pressure below 100, so the nurse knows when giving the drug would cause harm.